Topics
News
CME/CE
Editorial Advisory Board
Partners
Subscribe
- General Dermatology
- Eczema
- Chronic Hand Eczema
- Alopecia
- Aesthetics
- Vitiligo
- COVID-19
- Actinic Keratosis
- Precision Medicine and Biologics
- Rare Disease
- Wound Care
- Rosacea
- Psoriasis
- Psoriatic Arthritis
- Atopic Dermatitis
- Melasma
- NP and PA
- Skin Cancer
- Hidradenitis Suppurativa
- Drug Watch
- Pigmentary Disorders
- Acne
- Pediatric Dermatology
- Practice Management
- Prurigo Nodularis
Opinion
Video
Role of PDE-4 in the Management of Plaque Psoriasis
Author(s):
Focusing on treatment paradigms in plaque psoriasis, E. James Song, MD, FAAD, provides insights on phosphodiesterase inhibitors 4 (PDE-4) and their role in the therapeutic landscape.
EP: 1.Evolution of Plaque Psoriasis Understanding, Pathophysiology, and Treatment Options
EP: 2.Morphological Differences of Plaque Psoriasis vs Eczema Skin Conditions
Now Viewing
EP: 3.Role of PDE-4 in the Management of Plaque Psoriasis
EP: 4.Management of Plaque Psoriasis in a 45-year-old Woman via Telemedicine
EP: 5.Optimizing Therapy Escalation: Navigating Insurance Barriers and Step Therapy for Patients with Plaque Psoriasis
EP: 6.Case 1: Evaluating Treatment History and Future Management Strategies for a Patient with Mild-to-Moderate Plaque Psoriasis
EP: 7.Comparison of Systemic Therapies for Plaque Psoriasis
EP: 8.Case 2: Management of a 58-Year-Old Patient with Location-Specific Plaque Psoriasis, Psoriatic Arthritis, Type 2 Diabetes, and Obesity
Related Videos
Related Content
